US Broker Ratings

AbbVie Inc. (ABBV): Investor Outlook and Potential Upside Amidst Strong Market Position

AbbVie Inc. (NYSE: ABBV) continues to make waves in the healthcare sector, boasting a robust market capitalization of $394.89 billion and a noteworthy presence in the..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Giant with a Strong Dividend Yield

Merck & Company, Inc. (MRK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and strategic operations across pharmaceutical..

Centene Corporation (CNC) Stock Analysis: Evaluating a 14.10% Potential Upside in Healthcare Plans

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, specializes in providing programs and services for under-insured and uninsured families in the United States...

Medtronic plc (MDT) Stock Analysis: Navigating the Healthcare Giant’s 7.75% Upside Potential

Medtronic plc (NYSE: MDT), a titan in the healthcare sector, continues to attract investor attention with its robust product offerings and potential for growth. As a..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings with a 22% Upside Potential

Danaher Corporation (NYSE: DHR), a key player in the Healthcare sector, continues to capture investor interest with its robust market presence and potential for growth. With..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with Steady Growth and Modest Upside

Investors might find McKesson Corporation (NYSE: MCK) an intriguing prospect given its commanding presence in the healthcare sector, particularly in medical distribution. With a market capitalization..

HCA Healthcare, Inc. (HCA) Stock Analysis: A 5.35% Potential Upside Amid Strong Revenue Growth

HCA Healthcare, Inc. (NYSE: HCA) stands at the forefront of the U.S. healthcare sector, commanding a formidable presence with its vast network of medical care facilities...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Insights on Growth Potential and Analyst Ratings

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, focusing primarily on innovative therapies for cystic fibrosis (CF) and expanding its..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 5.48% Potential Upside Amidst a Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a cornerstone of the healthcare sector and renowned for its biopharmaceutical prowess, remains a focal point for investors eyeing stability coupled with..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 22.77% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a prominent player in the healthcare sector, continues to capture investor interest with its robust market cap of $203.95 billion..

Amgen Inc. (AMGN) Stock Analysis: Navigating Healthcare Growth with a Robust Pipeline and a Promising Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, is a name synonymous with innovation and stability in the pharmaceutical industry. With a market capitalization..

Verastem, Inc. (VSTM) Stock Analysis: Exploring the 164.73% Potential Upside in Biotech Innovation

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with its promising potential upside of 164.73%, according to recent analyst ratings. This biopharmaceutical company, headquartered..

Emergent BioSolutions (EBS) Stock Analysis: Exploring a 28% Potential Upside Amid Healthcare Innovations

Emergent BioSolutions Inc. (NYSE: EBS), renowned for its pivotal role in public health threat preparedness, is garnering attention from investors due to its notable 28.08% potential..

Rapport Therapeutics, Inc. (RAPP) Investor Outlook: A 100% Upside Potential in Biotech Sector

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, is attracting attention with its ambitious focus on developing transformational small molecule medicines for..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring the 25% Potential Upside Amid Market Challenges

Standard BioTools Inc. (NASDAQ: LAB) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $476.86 million,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Biotech Innovator with 69.49% Potential Upside

MBX Biosciences, Inc. (MBX), a beacon of innovation in the healthcare sector, is capturing investor attention with its promising pipeline of precision peptide therapies. As a..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Unpacking a 169.66% Potential Upside with Robust Revenue Growth

Investors eyeing the biotechnology sector may find Zevra Therapeutics, Inc. (NASDAQ: ZVRA) an intriguing proposition. This U.S.-based company, with a market capitalization of $470.65 million, is..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a Biotech Gem with Over 110% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline of cancer therapies. Specializing in developing treatments..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 49.91% Upside Potential for Investors

Castle Biosciences, Inc. (NASDAQ: CSTL), a dynamic player in the healthcare sector specializing in molecular diagnostics, is catching the attention of investors with its promising potential...

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 77% Upside Potential in the Biotech Sector

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company headquartered in Menlo Park, California, is capturing investors’ attention with a significant potential upside of 77.17%, according..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds